Controlled induction of immune tolerance by mesenchymal stem cells transferred by maternal microchimerism

Sayuri Iwai,Aiko Okada,Kei Sasano,Masayuki Endo,Sho Yamazaki,Xin Wang,Takashi Shimbo,Takuji Tomimatsu,Tadashi Kimura,Katsuto Tamai
DOI: https://doi.org/10.1016/j.bbrc.2020.12.032
2021-02-05
Abstract:Feto-maternal immune tolerance is established during pregnancy; however, its mechanism and maintenance remain underexplored. Here, we investigated whether mesenchymal stem/stromal cells (MSCs) as non-inherited maternal antigens (NIMAs) transferred by maternal microchimerism could induce immune tolerance. We showed that MSCs had a potential equivalent to hematopoietic stem and progenitor cells (HSPCs) to induce immune tolerance and that MSCs were essential to induce tolerance to MSC-specific antigens. Furthermore, we demonstrated that MSCs as NIMAs transferred by maternal microchimerism could induce robust immune tolerance that can be further enhanced using a drug. Our data shed light on induction of immune tolerance and serve as a foundation to develop new therapies using maternally derived cells for autoimmune or genetic diseases.
What problem does this paper attempt to address?